**Core Concept**
Irritable bowel syndrome with constipation (IBS-C) is a gastrointestinal disorder characterized by abdominal pain, bloating, and difficulty passing stools. The primary goal of treatment is to relieve symptoms and improve bowel habits. Lubiprostone is a type of chloride channel activator that increases intestinal fluid secretion and promotes bowel movements.

**Why the Correct Answer is Right**
Lubiprostone works by activating the cystic fibrosis transmembrane conductance regulator (CFTR) and the calcium-activated chloride channel (CaCC) in the intestinal epithelium, leading to increased secretion of chloride and water into the intestinal lumen. This results in softening of stool and improvement in bowel habits. Lubiprostone is specifically indicated for the treatment of IBS-C in women, as it has been shown to increase bowel movements and reduce symptoms.

**Why Each Wrong Option is Incorrect**
**Option B:** Loperamide is an opioid receptor agonist that slows down gut motility and increases the transit time of stool through the intestines, which is the opposite of what is desired in IBS-C. It is actually used to treat diarrhea, not constipation.
**Option C:** Alosetron is a serotonin 5-HT3 receptor antagonist that slows down gut motility and is used to treat severe diarrhea-predominant IBS (IBS-D) in women, not IBS-C.
**Option D:** Clonidine is an alpha-2 adrenergic receptor agonist that can slow down gut motility and is used to treat hypertension, ADHD, and opioid withdrawal, but it is not indicated for the treatment of IBS-C.

**Clinical Pearl / High-Yield Fact**
Lubiprostone is a unique medication that works by increasing intestinal fluid secretion, rather than altering gut motility. This mechanism of action makes it a valuable option for patients with IBS-C who have not responded to other treatments.

✓ Correct Answer: A. Lubiprostone